Back to search
FDAFDA · Food and drugs·Recall number D-0889-2017

Estradiol 25 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF, in 1 count, 12 count, and 30 count bottles, Sterile Office Use Only, For Subcutaneous Use Only. Rx Only ,Manufactured by: Qualgen 14844 Bristol Park Blvd Edmond, OK 73013 NDC 69761-025-01,

Published June 14, 2017 · Recall initiated: April 19, 2017

Summary

FDA records drug Class II recall D-0889-2017, published June 14, 2017 and initiated April 19, 2017. Recalling firm: Qualgen; Status: Terminated; Reported quantity: 1,153 pellets.; Lot: Lot # C031; Exp. 03/2/18 Lot # B077; Exp. 08/10/17 Lot # B040; Exp. 05/16/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviations- Lack of Quality Assurance

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Qualgen
Distributor
Nationwide.
Lot
Lot # C031; Exp. 03/2/18 Lot # B077; Exp. 08/10/17 Lot # B040; Exp. 05/16/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Estradiol 25 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF, in 1 count, 12 count, and 30 count bottles, Sterile Office Use Only, For Subcutaneous Use Only. Rx Only ,Manufactured by: Qualgen 14844 Bristol Park Blvd Edmond, OK 73013 NDC 69761-025-01, recalled?

Yes. FDA published recall D-0889-2017 on June 14, 2017. Reported hazard: CGMP deviations- Lack of Quality Assurance

What should I do if I have this product?

Voluntary: Firm initiated · Letter